During the past decade, Q-Pharm Pty Limited conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Q-Pharm Pty Limited" are "Avian Influenza" (1 trials), "Covid19" (1 trials), "Healthy" (1 trials), "Influenza" (1 trials) and "Prophylaxis of Ross River Virus Infection" (1 trials). Many other conditions were trialed in "Q-Pharm Pty Limited" in a lesser frequency.

Most popular intervention types in "Q-Pharm Pty Limited" are "Biological" (3 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Adjuvant 1" (1 trials), "BGB DXP593" (1 trials), "BGB-DXP593" (1 trials) and "BGB-DXP604" (1 trials). Other intervention names were less common.

The vast majority of trials in "Q-Pharm Pty Limited" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Q-Pharm Pty Limited". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Q-Pharm Pty Limited, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Q-Pharm Pty Limited, 4 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".